Abbott's weak medical device sales, China impact drag shares down...
dailymail.co.uk
news
2022-10-19 14:04:14

By Reuters Published: 10:04 EDT, 19 October 2022 | Updated: 10:04 EDT, 19 October 2022 Oct 19 (Reuters) - Abbott Laboratories on Wednesday reported lower-than-expected growth in international medical device sales, hit by a strong dollar and supply challenges in China, dragging down shares of the company nearly 7%. The U.S.-based company's weak medical device sales in markets outside its home country offset the initial enthusiasm over its quarterly beat and an upbeat forecast. Abbott reported $3.62 billion in overall medical device sales, down 0.
